These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 16804393)

  • 61. Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome.
    Sydora MJ; Sydora BC; Fedorak RN
    J Crohns Colitis; 2012 Mar; 6(2):207-14. PubMed ID: 22325175
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Comparison of Fecal Inflammatory Markers in Crohn's Disease.
    Wright EK; Kamm MA; De Cruz P; Hamilton AL; Ritchie KJ; Keenan JI; Leach S; Burgess L; Aitchison A; Gorelik A; Liew D; Day AS; Gearry RB
    Inflamm Bowel Dis; 2016 May; 22(5):1086-94. PubMed ID: 26818420
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Fecal HMGB1 is a novel marker of intestinal mucosal inflammation in pediatric inflammatory bowel disease.
    Vitali R; Stronati L; Negroni A; Di Nardo G; Pierdomenico M; del Giudice E; Rossi P; Cucchiara S
    Am J Gastroenterol; 2011 Nov; 106(11):2029-40. PubMed ID: 21788990
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Altered Fecal Microbiota in Paediatric Inflammatory Bowel Disease.
    Maukonen J; Kolho KL; Paasela M; Honkanen J; Klemetti P; Vaarala O; Saarela M
    J Crohns Colitis; 2015 Dec; 9(12):1088-95. PubMed ID: 26351391
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Fecal neutrophil gelatinase-associated lipocalin is a surrogate marker of inflammation in inflammatory bowel disease].
    Zinkevich OD; Mukhametova DD; Abdulganieva DI; Safina NA; Koporulina MO; Odintsova AKh
    Eksp Klin Gastroenterol; 2014; (10):22-7. PubMed ID: 25911926
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Fecal biomarkers in the diagnosis and monitoring of Crohn's disease.
    Wright EK; De Cruz P; Gearry R; Day AS; Kamm MA
    Inflamm Bowel Dis; 2014 Sep; 20(9):1668-77. PubMed ID: 24918319
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Inflammatory bowel disease detection and monitoring by measuring biomarkers in non-invasively collected colorectal mucus.
    Loktionov A; Chhaya V; Bandaletova T; Poullis A
    J Gastroenterol Hepatol; 2017 May; 32(5):992-1002. PubMed ID: 27787913
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Disease activity assessment in IBD: clinical indices and biomarkers fail to predict endoscopic remission.
    Falvey JD; Hoskin T; Meijer B; Ashcroft A; Walmsley R; Day AS; Gearry RB
    Inflamm Bowel Dis; 2015 Apr; 21(4):824-31. PubMed ID: 25738372
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Fecal calprotectin and C-reactive protein are associated with positive findings in capsule endoscopy in suspected small bowel Crohn's disease.
    Egea Valenzuela J; Pereñíguez López A; Pérez Fernández V; Alberca de Las Parras F; Carballo Álvarez F
    Rev Esp Enferm Dig; 2016 Jul; 108(7):394-400. PubMed ID: 27312194
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Fecal pyruvate kinase: a potential new marker for intestinal inflammation in children with inflammatory bowel disease.
    Czub E; Herzig KH; Szaflarska-Popawska A; Kiehne K; Socha P; Woś H; Kamińska B; Błaszczyński M; Cichy W; Bała G; Brodzicki J; Grzybowska-Chlebowczyk U; Walkowiak J
    Scand J Gastroenterol; 2007 Oct; 42(10):1147-50. PubMed ID: 17852864
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Active Crohn's disease and ulcerative colitis can be specifically diagnosed and monitored based on the biostructure of the fecal flora.
    Swidsinski A; Loening-Baucke V; Vaneechoutte M; Doerffel Y
    Inflamm Bowel Dis; 2008 Feb; 14(2):147-61. PubMed ID: 18050295
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Fecal biomarkers in inflammatory bowel disease: how, when and why?
    Ministro P; Martins D
    Expert Rev Gastroenterol Hepatol; 2017 Apr; 11(4):317-328. PubMed ID: 28276813
    [TBL] [Abstract][Full Text] [Related]  

  • 73. S100A12 is a novel molecular marker differentiating systemic-onset juvenile idiopathic arthritis from other causes of fever of unknown origin.
    Wittkowski H; Frosch M; Wulffraat N; Goldbach-Mansky R; Kallinich T; Kuemmerle-Deschner J; Frühwald MC; Dassmann S; Pham TH; Roth J; Foell D
    Arthritis Rheum; 2008 Dec; 58(12):3924-31. PubMed ID: 19035478
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Does fecal calprotectin predict relapse in patients with Crohn's disease and ulcerative colitis?
    García-Sánchez V; Iglesias-Flores E; González R; Gisbert JP; Gallardo-Valverde JM; González-Galilea A; Naranjo-Rodríguez A; de Dios-Vega JF; Muntané J; Gómez-Camacho F
    J Crohns Colitis; 2010 Jun; 4(2):144-52. PubMed ID: 21122498
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Association of clinical characteristics and lifestyle factors with fecal S100/calgranulin concentrations in healthy dogs.
    Heilmann RM; Guard MM; Toresson L; Unterer S; Grellet A; Grützner N; Suchodolski JS; Steiner JM
    Vet Med Sci; 2021 Jul; 7(4):1131-1143. PubMed ID: 33751838
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Fecal MMP-9: a new noninvasive differential diagnostic and activity marker in ulcerative colitis.
    Annaházi A; Molnár T; Farkas K; Rosztóczy A; Izbéki F; Gecse K; Inczefi O; Nagy F; Földesi I; Szűcs M; Dabek M; Ferrier L; Theodorou V; Bueno L; Wittmann T; Róka R
    Inflamm Bowel Dis; 2013 Feb; 19(2):316-20. PubMed ID: 22550024
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Role of HMGB1 as a suitable biomarker of subclinical intestinal inflammation and mucosal healing in patients with inflammatory bowel disease.
    Palone F; Vitali R; Cucchiara S; Pierdomenico M; Negroni A; Aloi M; Nuti F; Felice C; Armuzzi A; Stronati L
    Inflamm Bowel Dis; 2014 Aug; 20(8):1448-57. PubMed ID: 24983978
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation.
    Kane SV; Sandborn WJ; Rufo PA; Zholudev A; Boone J; Lyerly D; Camilleri M; Hanauer SB
    Am J Gastroenterol; 2003 Jun; 98(6):1309-14. PubMed ID: 12818275
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Accuracy of four fecal assays in the diagnosis of colitis.
    Schoepfer AM; Trummler M; Seeholzer P; Criblez DH; Seibold F
    Dis Colon Rectum; 2007 Oct; 50(10):1697-706. PubMed ID: 17762964
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Improved diagnosis of colorectal cancer using a combination of fecal occult blood and novel fecal protein markers.
    Karl J; Wild N; Tacke M; Andres H; Garczarek U; Rollinger W; Zolg W
    Clin Gastroenterol Hepatol; 2008 Oct; 6(10):1122-8. PubMed ID: 18928937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.